Vaccine therapy for malignant melanoma

CA Cancer J Clin. Jul-Aug 1996;46(4):225-44. doi: 10.3322/canjclin.46.4.225.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Combined Modality Therapy
  • Humans
  • Immunotherapy, Active*
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Melanoma / immunology
  • Melanoma / mortality
  • Melanoma / therapy*
  • Recombinant Proteins
  • Remission Induction
  • Skin Neoplasms / immunology
  • Skin Neoplasms / mortality
  • Skin Neoplasms / therapy*
  • Survival Rate

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins